TrialJournal of translational medicine2012

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.

Koji Kono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.